Cancer as a Cause of Death among People with AIDS in the United States

被引:127
作者
Simard, Edgar P. [1 ]
Engels, Eric A. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20892 USA
基金
美国国家卫生研究院;
关键词
ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PERSONS; LUNG-CANCER; MORTALITY; DIAGNOSIS; LYMPHOMA; INCREASE; TRENDS; EPOCH;
D O I
10.1086/656416
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. People with human immunodeficiency virus (HIV) infection and AIDS have an elevated risk for cancer. Highly active antiretroviral therapy (HAART), which has been widely available since 1996, has resulted in dramatic decreases in AIDS-related deaths. Methods. We evaluated cancer as a cause of death in a US registry-based cohort of 83,282 people with AIDS (1980-2006). Causes of death due to AIDS-defining cancers (ADCs) and non-ADCs (NADCs) were assessed. We evaluated mortality rates and the fraction of deaths due to cancer. Poisson regression assessed rates according to calendar year of AIDS onset. Results. Overall mortality decreased from 302 deaths per 1000 person-years in 1980-1989, to 140 deaths per 1000 person-years in 1990-1995, and to 29 deaths per 1000 person-years in 1996-2006. ADC-related mortality decreased from 2.95 deaths per 1000 person-years in 1980-1989 to 0.65 deaths per 1000 person-years in 19962006 (P<.01), but the fraction of ADC-related deaths increased from 1.05% to 2.47% in association with decreases in other AIDS-related deaths. Non-Hodgkin lymphoma was the most common cancer-related cause of death (36% of deaths during 1996-2006). Likewise, NADC-related mortality decreased from 2.21 to 0.84 deaths per 1000 person-years from the period 1980-1989 to the period 1996-2006 (P<.05), but the fraction of NADC-deaths increased to 3.16% during 1996-2006. Lung cancer was the most common NADC cause of death (21% of cancer-related deaths in 1996-2006). Conclusions. Cancer-related mortality decreased in the HAART era, but because of decreasing mortality due to AIDS, cancers account for a growing fraction of deaths. Improved cancer prevention and treatment, particularly for non-Hodgkin lymphoma and lung cancer, would reduce mortality among people with AIDS.
引用
收藏
页码:957 / 962
页数:6
相关论文
共 31 条
  • [1] [Anonymous], 1992, MMWR Recomm. Rep, V41
  • [2] [Anonymous], 1977, INT CLASS DIS MAN IN
  • [3] Survival after cancer diagnosis in persons with AIDS
    Biggar, RJ
    Engels, EA
    Ly, S
    Kahn, A
    Schymura, MJ
    Sackoff, J
    Virgo, P
    Pfeiffer, RM
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) : 293 - 299
  • [4] Changes in Cancer Mortality among HIV-Infected Patients: The Mortalite 2005 Survey
    Bonnet, Fabrice
    Burty, Christine
    Lewden, Charlotte
    Costagliola, Dominique
    May, Thierry
    Bouteloup, Vincent
    Rosenthal, Eric
    Jougla, Eric
    Cacoub, Patrice
    Salmon, Dominique
    Chene, Genevieve
    Morlat, Philippe
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (05) : 633 - 639
  • [5] Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: Implications for patient care
    Brock, Malcolm V.
    Hooker, Craig M.
    Engels, Eric A.
    Moore, Richard D.
    Gillison, Maura L.
    Alberg, Anthony J.
    Keruly, Jeanne C.
    Yang, Stephen C.
    Heitmiller, Richard F.
    Baylin, Stephen B.
    Herman, James G.
    Brahmer, Julie R.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (01) : 47 - 55
  • [6] THE MIGRATION OF PERSONS WITH AIDS - DATA FROM 12 STATES, 1985 TO 1992
    BUEHLER, JW
    FREY, RL
    CHU, SY
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (11) : 1552 - 1555
  • [7] Comparisons of causes of death and mortality rates among HIV-infected persons - Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras
    Crum, NF
    Riffenburgh, RH
    Wegner, S
    Agan, BK
    Tasker, SA
    Spooner, KM
    Armstrong, AW
    Fraser, S
    Wallace, MR
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (02) : 194 - 200
  • [8] Presentation and outcomes of systemic non-Hodgkin's lymphoma: A comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS
    Diamond, Catherine
    Taylor, Thomas H.
    Im, Theresa
    Anton-Culver, Hoda
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (09) : 1822 - 1829
  • [9] The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma
    Dunleavy, Kieron
    Little, Richard F.
    Pittaluga, Stefania
    Grant, Nicole
    Wayne, Alan S.
    Carrasquillo, Jorge A.
    Steinberg, Seth M.
    Yarchoan, Robert
    Jaffe, Elaine S.
    Wilson, Wyndham H.
    [J]. BLOOD, 2010, 115 (15) : 3017 - 3024
  • [10] Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
    El-Serag, Hashem B.
    Rudolph, Lenhard
    [J]. GASTROENTEROLOGY, 2007, 132 (07) : 2557 - 2576